$MGRX will market and sell KYZATREX®️, a FDA-approved oral Testosterone Replacement Therapy product, as 'PRIME' by MangoRx starting January 31, 2024 https://www.nasdaq.com/press-release/mangoceuticals-to-introduce-prime-powered-by-kyzatrexr-ciii-testosterone-undecanoate